๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease

โœ Scribed by Mark S. Baron; W. Brian Dalton


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
109 KB
Volume
18
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Therapies for dopaminergic-induced dyski
โœ Mildred D. Gottwald; Michael J. Aminoff ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 230 KB ๐Ÿ‘ 2 views

## Abstract Existing and emerging strategies for managing Lโ€dopaโ€“induced dyskinesias (LIDs) in patients with Parkinson disease have involved either delaying the introduction of Lโ€dopa therapy, treatment with an antidyskinetic agent, using a therapy or delivery system that can provide continuous dop

โ€œSilly Walksโ€ in Parkinson's disease: Un
โœ Evลพen Rลฏลพiฤka; Kateล™ina Zรกrubovรก; John G. Nutt; Bastiaan R. Bloem ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 486 KB ๐Ÿ‘ 1 views

Celiac disease (CD), which is one of the most important malabsorptive diseases in adults, has been associated with several neurological disorders including peripheral neuropathy, cerebellar ataxia, myopathy, and attention deficit hyperactivity disorders. Recently, 2 independent studies 1,2 reported